Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: IBSA Farmaceutici Italia Srl, Via Martiri di Cefalonia 2, 26900, Lodi (Italy)
AKIS 75 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear to slightly amber coloured transparent solution. |
The active ingredient is diclofenac sodium.
Each 1 ml ampoule contains: 75 mg of diclofenac sodium.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
| List of Excipients |
|---|
|
Hydroxypropylbetadex |
Transparent type I glass ampoule.
Package of 1, 3 and 5 ampoules.
Not all pack sizes may be marketed.
IBSA Farmaceutici Italia Srl, Via Martiri di Cefalonia 2, 26900, Lodi (Italy)
PL 21039/0042
13/10/2017
| Drug | Countries | |
|---|---|---|
| AKIS | Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
